{
    "organizations": [],
    "uuid": "92fda11bbc3cb036c9f3f253a2928ede4d270642",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncosec-medical-says-board-determi/brief-oncosec-medical-says-board-determined-to-consolidate-roles-of-ceo-and-president-idUSFWN1SB19V",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncosec Medical Says Board Determined To Consolidate Roles Of CEO And President",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 4 (Reuters) - OncoSec Medical Inc:\n* ONCOSEC MEDICAL INC - BOARD DETERMINED TO CONSOLIDATE ROLES OF CHIEF EXECUTIVE OFFICER AND PRESIDENT\n* ONCOSEC MEDICAL INC - PUNIT DHILLON WILL NO LONGER SERVE AS PRESIDENT OF COMPANY, BUT WILL REMAIN AS A MEMBER OF BOARD OF DIRECTORS\n* ONCOSEC MEDICAL INC - DANIEL CONNOR TO SERVE AS BOTH CHIEF EXECUTIVE OFFICER AND PRESIDENT - SEC FILING Source text: ( bit.ly/2FKaNaz ) Further company coverage:\n ",
    "published": "2018-05-05T04:07:00.000+03:00",
    "crawled": "2018-05-05T12:05:08.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "oncosec",
        "medical",
        "inc",
        "oncosec",
        "medical",
        "inc",
        "board",
        "determined",
        "consolidate",
        "role",
        "chief",
        "executive",
        "officer",
        "president",
        "oncosec",
        "medical",
        "inc",
        "punit",
        "dhillon",
        "longer",
        "serve",
        "president",
        "company",
        "remain",
        "member",
        "board",
        "director",
        "oncosec",
        "medical",
        "inc",
        "daniel",
        "connor",
        "serve",
        "chief",
        "executive",
        "officer",
        "president",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}